Monitoring of direct oral anticoagulants plasma levels for secondary stroke prevention-Reference-Cited by-同舟云学术

Monitoring of direct oral anticoagulants plasma levels for secondary stroke prevention

Published:2022-05 Issue:5 Volume:20 Page:1138-1145
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Siedler Gabriela^ORCID,Macha Kosmas,Stoll Svenja,Plechschmidt Johannes,Wang Ruihao,Gerner Stefan T.,Strasser Erwin,Schwab Stefan,Kallmünzer Bernd^ORCID

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15677

Reference35 articles.

1. Atrial fibrillation is associated with a worse 90‐day outcome than other cardioembolic stroke subtypes;Henninger;Stroke,2016

2. Stroke prevention in atrial fibrillation: state of the art;Li;Int J Cardiol,2019

3. Antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation: the GLORIA‐AF registry, Phase II;Huisman;Am J Med,2015

4. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association;Camm;Eur Heart J,2012

5. Association of preceding antithrombotic treatment with acute ischemic stroke severity and in‐hospital outcomes among patients with atrial fibrillation;Xian;JAMA,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveling the playing field: The role of level‐based dosing in pediatric anticoagulation management;Pediatric Blood & Cancer;2024-07-05

2. Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke—A case control study;PLOS ONE;2024-04-25

3. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study;Blood Advances;2024-04-10

4. Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study;Frontiers in Neurology;2023-12-15

5. LOW LEVELS OF DIRECT ORAL ANTICOAGULANTS AT STEADY STATE IN ATRIAL FIBRILLATION PATIENTS WHO LATER DEVELOP THROMBOTIC COMPLICATIONS; THE PROSPECTIVE MAS (MEASURE AND SEE) STUDY;2023-12-10